"L' Istituto Neurologico "Carlo Besta" è un polo di eccellenza per la ricerca e la cura delle più significative malattie neurologiche. Il Besta coniuga in modo sinergico le attività di ricerca scientifica, di diagnosi e cura – che danno origine ad un continuo miglioramento dell’efficacia terapeutica – nell’ambito della neurologica clinica e di base e si occupa dei disturbi neurologici dell’adulto e del bambino, delle patologie neurochirurgiche ed oncologiche, delle malattie croniche e rare."

During the past decade, Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica" are "Huntington Disease" (1 trials) and "Huntingtons Disease" (1 trials). Many other conditions were trialed in "Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica" in a lesser frequency.

Most popular intervention types in "Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "RO7234292" (1 trials) and "RO7234292 (RG6042)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione IRCCS Istituto Neurologico Carlo Besta; U.O.C. Genetica Medica-Neurogenetica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".